Related Experiment Video

Updated: May 9, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Pancreatic cancer

Susanne Roth^1,2, Minoti Apte³, Vinod P Balachandran^4,5

¹Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Nature Reviews. Disease Primers

|May 7, 2026

Abstract:

Pancreatic ductal adenocarcinoma remains one of the deadliest malignancies, characterized by late diagnosis, aggressive biology and limited therapeutic success. Advances in multiagent chemotherapy have improved outcomes across disease stages, whereas precision medicine approaches are reshaping treatment paradigms. Personalized RNA vaccines and oncogenic KRAS-directed agents represent emerging immunological and molecular frontiers. Multimodal treatment regimens and surgical innovations, including vessel-oriented and minimally invasive techniques, have enhanced complete resection rates and enabled conversion of initially unresectable locally advanced pancreatic cancer into resectable disease. Increasingly, multidisciplinary, biology-guided strategies define resectability and the sequence of systemic and local therapies. The tumour microenvironment's complex stromal and immune ecology remains central to therapeutic resistance but also offers opportunities for rational combination therapy. Early detection and risk-adapted surveillance for high-risk individuals are advancing, as are artificial intelligence-assisted imaging and liquid biopsy approaches. Despite persistent challenges, the convergence of mechanistic insights, precision therapeutics and supportive care provides a framework for transforming pancreatic ductal adenocarcinoma from an inevitably lethal disease towards a better manageable condition.

Insights

Pancreatic cancer (PDAC) treatment is advancing with precision medicine, RNA vaccines, and surgical innovations. These strategies aim to improve outcomes and transform PDAC into a manageable disease.

Area of Science:

Oncology
Surgical Oncology
Immunotherapy

Background:

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with poor prognosis.
Limited therapeutic success and late diagnosis are key challenges in managing PDAC.

Purpose of the Study:

To review recent advances in pancreatic cancer treatment.
To highlight emerging frontiers in immunotherapy and precision medicine for PDAC.
To discuss innovations in surgical techniques and multidisciplinary approaches.

Main Methods:

Review of multiagent chemotherapy, personalized RNA vaccines, and KRAS-directed agents.
Analysis of multimodal treatment regimens and surgical innovations (vessel-oriented, minimally invasive).
Exploration of multidisciplinary, biology-guided strategies for resectability and therapy sequencing.
Discussion of tumor microenvironment, early detection, AI-assisted imaging, and liquid biopsy.

Main Results:

Multiagent chemotherapy has improved outcomes across disease stages.
Precision medicine, RNA vaccines, and KRAS-directed agents are emerging treatment paradigms.
Surgical innovations enhance resection rates and convert unresectable tumors to resectable.
Multidisciplinary strategies are increasingly defining resectability and therapy sequencing.

Conclusions:

Advances in systemic therapies, surgical techniques, and early detection offer a framework for improved pancreatic cancer management.
Targeting the tumor microenvironment and utilizing precision therapeutics are crucial for overcoming resistance.
The convergence of insights provides hope for transforming PDAC into a more manageable condition.

Read full analysis

Related Concept Videos

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Articles linked to this work by shared authors, journal, and citation graph.

Multi-stromal organoid co-culture modelling reveals epithelial-fibroblast heterogeneity in pancreatic cancer and pancreatitis.

Nature cell biology·2026

Tumor Location and Preoperative Biliary Stenting Shape Gut Microbiome Diversity in Pancreatic Cancer.

Cancers·2026

Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

Cancer research communications·2026

Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma.

JCO precision oncology·2026

Unique One-Stage Procedure: Simultaneous Patent Foramen Ovale Closure and Resection of Wilms Tumor With Vena Cava Thrombus in a 5-Year-Old.

Clinical case reports·2026

HYPOChLorous Acid TEsting Studies in percutaneous DRAINAGE (HYPOCLATES:DRAINAGE): protocol for a single-centre, controlled, ambispective cohort study comparing hypochlorous acid versus saline irrigation in percutaneous drainage of intra-abdominal abscesses.

BMJ open·2026

See all related articles